iShares Evolved U.S. Healthcare Staples ETF (IEHS) seeks to provide exposure to U.S. companies classified as having healthcare staples characteristics using BlackRock's proprietary Evolved Sector classification system. The ETF, managed by BlackRock Fund Advisors, invests at least 80% of its net assets in U.S.-listed common stocks of large-, mid-, and small-capitalization healthcare companies, with top sector allocations including health technology (54.4%); health services (31.55%); miscellaneous (4.47%); commercial services (4.31%); and distribution services (2.6%). It offers investors targeted access to healthcare staples via an index-tracking strategy focused on equity securities in the healthcare industry segment.
Launched as part of BlackRock's iShares Evolved suite, IEHS traces its origins to the broader iShares brand established in 2000 following the 1996 debut of precursor World Equity Benchmark Shares (WEBS), with BlackRock itself founded in 1988 and headquartered at 50 Hudson Yards, New York, New York. The fund advisor maintains offices including 400 Howard Street, San Francisco, California, and operates globally through BlackRock's network, though IEHS targets solely U.S. equities.
In a major strategic change, BlackRock announced the closure and liquidation of IEHS on June 17, 2022, as part of a review of its product lineup to align with evolving client needs; trading ceased after market close on August 22, 2022, with proceeds distributed to shareholders on August 25, 2022. This decision affected multiple Evolved ETFs, including IEHS alongside peers like IECS and IEFN, amid low assets under management and no subsequent relaunches or partnerships noted for the fund. Post-liquidation, the ETF no longer trades or accepts investments, marking its termination within the healthcare ETF category.